financetom
Business
financetom
/
Business
/
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Aug 14, 2024 1:28 PM

GeoVax Labs inc. ( GOVX ) and SIGA Technologies Inc. ( SIGA ) shares are surging Wednesday amid Mpox Emergency Declaration. Here’s what you need to know.

What Happened: The surge comes in response to reports that the World Health Organization (WHO) Director General has declared Mpox a public health emergency of international concern, which has heightened global focus on the disease.

Why It Matters:

GeoVax Labs ( GOVX ): GeoVax ( GOVX ) is a biotech company that focuses on developing vaccines for infectious diseases, including Mpox. The company has been involved in Mpox vaccine research and the WHO's emergency declaration has likely boosted investor confidence in the potential demand for its vaccine candidates.

SIGA Technologies ( SIGA ): SIGA Technologies ( SIGA ) specializes in developing countermeasures to treat smallpox and related diseases, including Mpox. Its antiviral drug, TPOXX (tecovirimat), has been used to treat Mpox, especially in severe cases. The increased focus on Mpox due to the WHO’s declaration has likely driven up investor interest in SIGA’s stock as demand for treatments like TPOXX could rise.

Recap of Recent Developments: The Mpox outbreak in the Democratic Republic of Congo and neighboring countries has escalated, leading the Africa Centres for Disease Control and Prevention (Africa CDC) to declare a public health emergency of continental security. This move marks the first time Africa CDC has declared such an emergency, emphasizing the severity of the outbreak. More than 15,000 Mpox cases and 461 deaths have been reported in Africa this year, with a significant increase in cases compared to last year according to Reuters.

The WHO is also convening an emergency committee to determine if the outbreak represents a global public health emergency. The situation has highlighted the urgent need for vaccines and treatments, though significant challenges remain, including limited vaccine supply and competing health crises.

Price Action (at publication Wednesday):

GOVX: GeoVax Labs’ shares were up by 30%, trading at $3.25.

SIGA ( SIGA ): SIGA Technologies’ shares saw an even greater increase, up by 27.04%, trading at $11.98.

Image via Unsplash.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PRESS DIGEST-Financial Times - March 23
PRESS DIGEST-Financial Times - March 23
Mar 22, 2026
March 23 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Poste Italiane launches 10.8 billion euro bid for Telecom Italia - Solo investor Air Street raises $232 million to chase hot AI bets - British energy supplier flags growing debt burden...
Japan Petroleum Association eyes North America for crude supply options
Japan Petroleum Association eyes North America for crude supply options
Mar 22, 2026
TOKYO, March 23 (Reuters) - Japan Petroleum Association President Shunichi Kito said on Monday that North America was one potential source for alternative crude oil supply to the Middle East, with Ecuador, Colombia and Mexico also possible options. Kito, who is also chairman of Japan's second-biggest oil refiner, Idemitsu Kosan ( IDKOF ) , added that there were no plans...
CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring
CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring
Mar 22, 2026
FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced it has entered into a definitive asset purchase agreement to acquire the business of DOASENSE GmbH, Heidelberg, a pioneer in specialized diagnostic solutions for Direct Oral Anticoagulants (DOACs). This strategic acquisition is...
Ping An investment arm questions US allocation
Ping An investment arm questions US allocation
Mar 22, 2026
HONG KONG, March 23 (Reuters) - Insurer Ping An's international arm is questioning further U.S. investments, its CEO said, citing the country's unreliability. The key question for me to consider is ... how much and whether you continue to deploy capital into the U.S. because ... the U.S. is becoming less reliable, said Hoi Tung, CEO and Chairman of Ping...
Copyright 2023-2026 - www.financetom.com All Rights Reserved